               SEQUENCE LISTING

<110> XIBER Science GmbH

<120> Peptides as active agents for treating primary graft dysfunction

<130> W1904 PCT S3

<150> EP13 18 0139.1
<151> 2013-08-12

<160> 45

<170> BiSSAP 1.2

<210> 1
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<220> 
<221> VARIANT
<222> 2
<223> Xaa is R or A

<220> 
<221> VARIANT
<222> 5
<223> Xaa is either omitted or L or V

<220> 
<221> VARIANT
<222> 6
<223> Xaa is either omitted or PPP

<220> 
<221> VARIANT
<222> 7
<223> Xaa is either omitted or GG

<220> 
<221> VARIANT
<222> 8
<223> Xaa is two amino acids selected from the group consisting of A, I
      and S

<220> 
<221> VARIANT
<222> 11
<223> Xaa is either omitted or an amino acid sequence consisting of 1
      to 5 amino acids

<400> 1
Gly Xaa Arg Pro Xaa Xaa Xaa Xaa Gly Gly Xaa 
1               5                   10      

<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<220> 
<221> VARIANT
<222> 6
<223> Xaa is either omitted or GG

<400> 2
Gly Arg Arg Pro Leu Xaa Ile Ser Gly Gly 
1               5                   10  

<210> 3
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide: XIB1-b

<400> 3
Gly Arg Arg Pro Leu Gly Gly Ile Ser Gly Gly 
1               5                   10      

<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 4
Gly Arg Arg Pro Leu Ile Ser Gly Gly 
1               5                   

<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<220> 
<221> VARIANT
<222> 6
<223> Xaa is either omitted or GG

<400> 5
Gly Arg Arg Pro Val Xaa Ile Ser Gly Gly 
1               5                   10  

<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 6
Gly Arg Arg Pro Val Gly Gly Ile Ser Gly Gly 
1               5                   10      

<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 7
Gly Arg Arg Pro Val Ile Ser Gly Gly 
1               5                   

<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 8
Gly Arg Arg Pro Leu Pro Pro Pro Ile Ser Gly Gly 
1               5                   10          

<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 9
Gly Arg Arg Pro Val Pro Pro Pro Ile Ser Gly Gly 
1               5                   10          

<210> 10
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 10
Gly Arg Arg Pro Leu Gly Gly Ala Ala Gly Gly 
1               5                   10      

<210> 11
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 11
Gly Arg Arg Pro Val Gly Gly Ala Ala Gly Gly 
1               5                   10      

<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 12
Gly Arg Arg Pro Leu Pro Pro Pro Ala Ala Gly Gly 
1               5                   10          

<210> 13
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 13
Gly Arg Arg Pro Val Pro Pro Pro Ala Ala Gly Gly 
1               5                   10          

<210> 14
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 14
Gly Arg Arg Pro Leu Gly Gly Ala Ser Gly Gly 
1               5                   10      

<210> 15
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 15
Gly Arg Arg Pro Val Gly Gly Ala Ser Gly Gly 
1               5                   10      

<210> 16
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 16
Gly Arg Arg Pro Leu Pro Pro Pro Ala Ser Gly Gly 
1               5                   10          

<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 17
Gly Arg Arg Pro Val Pro Pro Pro Ala Ser Gly Gly 
1               5                   10          

<210> 18
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 18
Gly Arg Arg Pro Leu Gly Gly Ile Ala Gly Gly 
1               5                   10      

<210> 19
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 19
Gly Arg Arg Pro Val Gly Gly Ile Ala Gly Gly 
1               5                   10      

<210> 20
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 20
Gly Arg Arg Pro Leu Pro Pro Pro Ile Ala Gly Gly 
1               5                   10          

<210> 21
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 21
Gly Arg Arg Pro Val Pro Pro Pro Ile Ala Gly Gly 
1               5                   10          

<210> 22
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 22
Gly Ala Arg Pro Leu Gly Gly Ile Ser Gly Gly 
1               5                   10      

<210> 23
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 23
Gly Ala Arg Pro Val Gly Gly Ile Ser Gly Gly 
1               5                   10      

<210> 24
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 24
Gly Ala Arg Pro Leu Pro Pro Pro Ile Ser Gly Gly 
1               5                   10          

<210> 25
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 25
Gly Ala Arg Pro Val Pro Pro Pro Ile Ser Gly Gly 
1               5                   10          

<210> 26
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 26
Gly Ala Arg Pro Leu Gly Gly Ala Ala Gly Gly 
1               5                   10      

<210> 27
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 27
Gly Ala Arg Pro Val Gly Gly Ala Ala Gly Gly 
1               5                   10      

<210> 28
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 28
Gly Ala Arg Pro Leu Pro Pro Pro Ala Ala Gly Gly 
1               5                   10          

<210> 29
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 29
Gly Ala Arg Pro Val Pro Pro Pro Ala Ala Gly Gly 
1               5                   10          

<210> 30
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 30
Gly Ala Arg Pro Leu Gly Gly Ala Ser Gly Gly 
1               5                   10      

<210> 31
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 31
Gly Ala Arg Pro Val Gly Gly Ala Ser Gly Gly 
1               5                   10      

<210> 32
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 32
Gly Ala Arg Pro Leu Pro Pro Pro Ala Ser Gly Gly 
1               5                   10          

<210> 33
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 33
Gly Ala Arg Pro Val Pro Pro Pro Ala Ser Gly Gly 
1               5                   10          

<210> 34
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 34
Gly Ala Arg Pro Leu Gly Gly Ile Ala Gly Gly 
1               5                   10      

<210> 35
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 35
Gly Ala Arg Pro Val Gly Gly Ile Ala Gly Gly 
1               5                   10      

<210> 36
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 36
Gly Ala Arg Pro Leu Pro Pro Pro Ile Ala Gly Gly 
1               5                   10          

<210> 37
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 37
Gly Ala Arg Pro Val Pro Pro Pro Ile Ala Gly Gly 
1               5                   10          

<210> 38
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> scrambled peptide

<400> 38
Gly Gly Gly Gly Gly Ser Arg Arg Ile Pro Leu 
1               5                   10      

<210> 39
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide: XIB1-a

<400> 39
Gly Arg Arg Pro Gly Gly Ala Ser Gly Gly 
1               5                   10  

<210> 40
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> random peptide

<400> 40
Gly Gly Gly Gly Gly Leu Ser Arg Arg Ile Pro 
1               5                   10      

<210> 41
<211> 28
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide Bbeta 15-42

<400> 41
Gly His Arg Pro Leu Asp Lys Lys Arg Glu Glu Ala Pro Ser Leu Arg 
1               5                   10                  15      
Pro Ala Pro Pro Pro Ile Ser Gly Gly Gly Tyr Arg 
            20                  25              

<210> 42
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<400> 42
Gly Arg Arg Pro Gly Gly Ile Ser Gly Gly 
1               5                   10  

<210> 43
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide with stretched shape

<400> 43
Gly Arg Arg Pro Ile Ser Gly Gly 
1               5               

<210> 44
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide without apparent shape

<400> 44
Gly Ala Ala Pro Gly Gly Ile Ser Gly Gly 
1               5                   10  

<210> 45
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> cingulin-derived peptide

<220> 
<221> VARIANT
<222> 2
<223> Xaa is R or A

<220> 
<221> VARIANT
<222> 5
<223> Xaa is either omitted or an amino acid selected from the group
      consisting of L and V

<220> 
<221> VARIANT
<222> 6
<223> Xaa is either omitted or an amino acid sequence consisting of 1
      to 5 amino acids

<220> 
<221> VARIANT
<222> 7
<223> Xaa is either omitted or GG

<220> 
<221> VARIANT
<222> 8
<223> Xaa is two amino acids selected from the group consisting of A, I
      and S

<220> 
<221> VARIANT
<222> 11
<223> Xaa is either omitted or an amino acid sequence consisting of 1
      to 5 amino acids

<400> 45
Gly Xaa Arg Pro Xaa Xaa Xaa Xaa Gly Gly Xaa 
1               5                   10      

